• 1:中国医师协会心血管内科医师分会
• 2:中国医院协会心脏康复管理专业委员会

摘要(Abstract)：

<正>《中国心血管健康与疾病报告2019概要》显示,目前我国心血管病患病率仍处于上升阶段,推算心血管病现患人数3.3亿,其中冠心病1100万例[1]。为做好冠状动脉粥样硬化性心脏病(以下简称冠心病)分级诊疗和康复医疗工作,国家卫生行政主管部门下发了《关于印发冠状动脉粥样硬化性心脏病和脑血管疾病分级诊疗技术方案的通知》(国卫办医函[2016]1424号)和《关于印发加快推进康复医疗工作发展意见的通知》(国卫医发[2021]19号)[2],详细阐述了冠心病分级诊疗服务流程、分级诊疗服务技术方案,

关键词(KeyWords)： 慢性冠状动脉综合征;运动康复;分级诊疗;专家共识

Abstract:

Keywords:

基金项目(Foundation):

作者(Author):

参考文献(References)：

• [1]中国心血管健康与疾病报告编写组.中国心血管健康与疾病报告2019概要.中国循环杂志，2020,35(9):833-854.
• [2]医政医管局.关于印发加快推进康复医疗工作发展意见的通知（国卫医发[2021]19号）.2021.06
• [3]Knuuti J,Wijns W,Saraste A,et al.2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes.Eur Heart J,2020,41(3):407-477.
• [4]Adamson PD,Newby DE,Hill CL,et al.Comparison of international guidelines for assessment of suspected stable angina:insights from the PROMISE and SCOT-HEART.JACC Cardiovasc Imaging,2018,11(19):1301-1310.
• [5]Reeh J,Therming CB,Heitmann M,et al.Prediction of obstructive coronary artery disease and prognosis in patients with suspected stable angina.Eur Heart J,2019,40(18):1426-1435．
• [6]Kunadian V,Chieff o A,Camici PG,et al.An EAPCI expert consensus document on ischaemia with non-obstructive coronary arteries in collaboration with European society of cardiology working group on coronary pathophysiologyµcirculation endorsed by coronary vasomotor disorders international study group.Eur Heart J,2020,41(37):3504-3520.
• [7]Merz CN,Pepine CJ,Walsh MN,et al.Ischemia and no obstructive coronary artery disease(INOCA):developing evidence-based therapies and research agenda for the next decade.Circulation,2017,135(11):1075-1092．
• [8]American Association of Cardiovascular&Pulmonary Rehabilitation.rehabilitation guidelines for cardiac rehabilitation programs.Sixth Edition.Champaign,IL:Human Kinetics,2021.
• [9]Kim C,Sung J,Lee JH,et al.Clinical practice guideline for cardiac rehabilitation in Korea.Ann Rehabil Med,2019,43(3):355-443.
• [10]Balady G,Ades PA,Bitner V,et al.Referral,enrollment and delivery of cardiac rehabilitation/secondary prevention programs at clinical centers and beyond:a presidential advisory from the American Heart Association.Circulation,2011,124(25):2951-2960.
• [11]Simon M,Korn K,Cho L,et al.Cardiac rehabilitation:a class 1 recommendation.Cleve Clin J Med,2018,85(7):551-558.
• [12]Leon AS,Franklin BA,Costa F,et al.Cardiac rehabilitation and secondary prevention of coronary heart disease:an American Heart Association scientifi c statement from the council on clinical cardiology and the council on nutrition,physical activity,and metabolism,in collaboration with the American Association of Cardiovascular and Pulmonary Rehabilitation.Circulation,2005,111(3):369-376.
• [13]霍勇，数说中国PCI的发展.第二十四届全国介入心脏病学论坛（CCIF 2021).2021.4.
• [14]Winnige P,Vysoky R,Dosbaba F,et al.Cardiac rehabilitation and its essential role in the secondary prevention of cardiovascular diseases.World J Clin Cases,2021,9(8):1761-1784.
• [15]Jiang H,Jia DL,Zhang BJ,et al.Exercise improves cardiac function and glucose metabolism in mice with experimental myocardial infarction through inhibiting HDAC4 and upregulating GLUT1 expression.Basic Res Cardiol,2020,115(3):28.
• [16]Ford TJ,Yii E,Sidik N,et al.Ischemia and No obstructive coronary artery disease:prevalence and correlates of coronary vasomotion disorders.Circ Cardiovasc Interv,2019,12(12):e008126．
• [17]Ford TJ,Stanley B,Good R,et al.Stratifi ed medical therapy using invasive coronary function testing in angina:the Cor Mic Atrial.J Am Coll Cardiol,2018,72(23Pt A):2841-2855.
• [18]Figulla HR,Lauten A,Maier LS,et al.Percutaneous coronary intervention in stable coronary heart disease-Is less more?Dtsch Arztebl Int,2020,117(9):137-144.
• [19]Pelliccia A,Sharma S,Gati S,et al.2020 ESC guidelines on sports cardiology and exercise in patients with cardiovascular disease.Eur Heart J,2021,42(1):17-96.
• [20]Achttien RJ,Staal JB,van der Voort S,et al.Exercise-based cardiac rehabilitation in patients with coronary heart disease:a practice guideline.Neth Heart J,2013,21(10):429-438.
• [21]中华人民共和国国家卫生健康委员会.关于印发冠状动脉粥样硬化性心脏病和脑血管疾病分级诊疗技术方案的通知.2017-02-09.
• [22]Hamm LF,Sanderson BK,Ades PA,et al.Core competencies for cardiac rehabilitation/secondary prevention professionals:2010 update:position statement of the American Association of Cardiovascular and Pulmonary Rehabilitation.J Cardiopulm Rehabil Prev,2011,31(1):2-10.
• [23]Gibbons RJ,Balady GJ,Bricker JT,et al.ACC/AHA 2002guideline update for exercise testing:summary article.Areport of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee to update the 1997 exercise testing guidelines).J Am Coll Cardiol,2002,40(8):1531-1540.
• [24]Price KJ,Gordon BA,Stephen RB,et al.A review of guidelines for cardiac rehabilitation exercise programmes:Is there an international consensus?Eur J Prev Cardiol,2016,23(16):1715-1733.
• [25]Phillips L,Wang JW,Gianos E,et al.Clinical role of the Duke Activity Status Index in the selection of the optimal type of stress myocardial perfusion imaging study in patients with known or suspected ischemic heart disease.J Nucl Cardiol,2011,18(6):1015-1020.
• [26]Dunlay SM,Manemann SM,Chamberlain AM,et al.Activities of daily living and outcomes in heart failure.Circ Heart Fail,2015,8(2):261-267.
• [27]Williams MA.Exercise testing in cardiac rehabilitation.Exercise prescription and beyond.Cardiol Clin,2001,19(3):415-431.
• [28]中国医师协会心血管内科医师分会预防与康复专业委员会.经皮冠状动脉介入治疗术后运动康复专家共识.中国介入心脏病学杂志，2016,24(7):361-369.
• [29]Keech A,Holgate K,Fildes J,et al.High-intensity interval training for patients with coronary artery disease:finding the optimal balance.Int J Cardiol,2020,298:8-14.
• [30]Dun Y,Thomas RJ,Medina-Inojosa JR,et al,High-intensity interval training in cardiac rehabilitation:impact on fat mass in patients with myocardial infarction.Mayo Clin Proc,2019,94:1718-1730.
• [31]Anderson L,Sharp GA,Norton RJ,et al.Home-based versus centre-based cardiac rehabilitation.Cochrane Database Syst Rev,2017,6(6):CD007130.
• [32]Hillis LD,Smith PK,Anderson JL,et al.2011 ACCF/AHAguideline for coronary artery bypass graft surgery:executive summary:a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines.Circulation,2011,124(23):2610-2642.
• [33]American College of Sports Medicine(ACSM).ACSM’s Guidelines for Exercise Testing and Prescription(Eleventh ed.).Wolters Kluwer,2021b.
• [34]Franklin BA,Lavie CJ,Squires RW,et al.Exercise-based cardiac rehabilitation and improvements in cardiorespiratory fitness:implications regarding patient benefit.Mayo Clinic Proceedings,2013,88(5):431-437.
• [35]Silva AK,Barbosa MP,Bernardo AF,et al.Cardiac risk stratification in cardiac rehabilitation programs:a review of protocols.Rev Bras Cir Cardiovasc,2014,29(2):255-265.
• [36]Fletcher GF,Ades PA,Kligfi eld P,et al.Exercise standards for testing and training:a scientifi c statement from the American Heart Association.Circulation,2013,128(8):873-934.
• [37]Duncan GE,Anton SD,Sydeman SJ,et al.Prescribing exercise at varied levels of intensity and frequency:a randomized trial.Arch Intern Med,2005,165(20):2362-2369.
• [38]Lee IM,Sesso HD,Oguma Y,et al.Relative intensity of physical activity and risk of coronary heart disease.Circulation,2003,107(8):1110-1116.
• [39]Garber CE,Blissmer B,Deschenes MR,et al.American College of Sports Medicine position stand.The quantity and quality of exercise for developing and maintaining cardiorespiratory,musculoskeletal,and neuromotor fitness in apparently healthy adults:guidance for prescribing exercise.Med Sci Sports Exerc,2011,43(7):1334-1359.
• [40]Piercy KL,Troiano RP,Ballard RM,et al.The Physical Activity Guidelines for Americans.JAMA,2018,320(19):2020-2028.
• [41]Borg G.Borg’s Perceived exertion and pain scales.Human Kinetics,1998:54-62.
• [42]Suaya JA,Stason WB,Ades PA,et al.Cardiac rehabilitation and survival in older coronary patients.J Am Coll Cardiol,2009,54(1):25-33.
• [43]Pollock M,Franklin B,Balady G,et al.Resistance exercise in individuals with and without cardiovascular disease:benefits,rationale,safety,and prescription:An advisory from the committee on exercise,rehabilitation,and prevention,council on clinical cardiology,AHA.Circulation,2000,101(7):823-833.
• [44]Williams MA,Haskell WL,Ades PA,et al.Resistance exercise in individuals with and without cardiovascular disease:2007update:a scientifi c statement from the American Heart Association council on clinical cardiolgy and council on nutrition,physical activity and metabolism.Circulation,2007,116(5):572-584.
• [45]Fletcher GF,Balady GJ,Amsterdam EA,et al.Exercise standards for testing and training:a statement for healthcare professionals from the American Heart Association.Circulation,2001,104(14):1694-1740.
• [46]Macedo RM,Faria-Neto JR,Costantini CO,et al.Phase I of cardiac rehabilitation:a new challenge for evidence based physiotherapy.World J Cardiol,2011,3(7):248-255.
• [47]Jette M,Sidney K,Blumchen G.Metabolic equivalents(METS)in exercise testing,exercise prescription,and evaluation of functional capacity.Clin Cardiol,1990,13(8):555-565.
• [48]O’Connor CM,Whellan DJ,Lee KL,et al.Effi cacy and safety of exercise training in patients with chronic heart failure:HF-ACTION Rrandomized controlled trial.JAMA,2009,301(14):1439-1450.
• [49]Peterson JA,Tharrett SJ.ACSM’s health/fi tness facility standards and guidelines.Champaign,IL:Human Kinetics,2012.
• [50]Balady GJ,Chaitman B,Driscoll D,et al.Recommendations for cardiovascular screening,staffi ng and emergency policies at health/fi tness facilities.Circulation,1998,97(22):2283-2293.
• [51]Perkins GD,Jacobs IG,Nadkarni VM,et al.Cardiac arrest and cardiopulmonary resuscitation outcome reports:update of the utstein resuscitation registry templates for out-of-hospital cardiac arrest.Circulation,2015,132(13):1286-300.
• [52]Kronick SL,Kurz MC,Lin S,et al.Part 4:Systems of care and continuous quality improvement:2015 American Heart Association guidelines update for cardiopulmonary resuscitation and emergency cardiovascular care.Circulation,2015,132(18Suppl 2):S397-S413.
• [53]Thomas RJ,Balady G,Banka G,et al.2018 ACC/AHA clinical performance and quality measures for cardiac rehabilitation:a report of the American College of Cardiology/American Heart Association task force on performance measures.J Am Coll Cardiol,2018,71(16):1814-1837.
• [54]Maron DJ,Hochman JS,Reynolds HR,et al.Initial invasive or conservative strategy for stable coronary disease.N Engl JMed,2020,382(15):1395-1407.
• [55]Park KW,Kang J,Kang SH,et al.The impact of residual coronary lesions on clinical outcomes after percutaneous coronary intervention:Residual SYNTAX score after percutaneous coronary intervention in patients from the Effi cacy of Xience/Promus versus Cypher in r Educing Late Loss after st ENTing (EXCELLENT)registry.Am Heart J,2014,167(3):384-392.e5.
• [56]Boden WE,O'Rourke RA,Teo KK,et al.Optimal medical therapy with or without pci for stable coronary disease.N Engl JMed,2007,356(15):1503-1516.
• [57]Frye RL,August P,Brooks MM,et al.A randomized trial of therapies for type 2 diabetes and coronary artery disease.N Engl JMed,2009,360(24):2503-2515.
• [58]Spertus JA,Jones PG,Maron DJ,et al.Health-status outcomes with invasive or conservative care in coronary disease.N Engl JMed,2020,382(15):1408-1419.
• [59]Risom SS,Zwisler AD,Johansen PP,et al.Exercise-based cardiac rehabilitation for adults with atrial fi brillation.Cochrane Database Syst Rev,2017,2(1):CD011197.
• [60]January CT,Wann LS,Calkins H,et al.2019 AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation:a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines and the Heart Rhythm Society in collaboration with the Society of Thoracic Surgeons.Circulation,2019,140(2):e125-e151.